Jonathan Block

Beauty Health Co (NASDAQ: SKIN) shares tanked in early trading on Tuesday, after reporting downbeat quarterly results. The results came amid an exciting earnings season. Here are some key analyst takeaways from the earnings release. Benchmark On Beauty Health Analyst Bruce Jackson downgraded the...

Amidst growing uncertainties and revised growth forecasts, Stifel Financial Corp (NYSE:SF) on Monday hit Beauty Health Co (NASDAQ:SKIN) with a downgrade, causing shares to sink more than 13% before a slight rebound. The SKIN Analyst: Jonathan Block downgraded Beauty Health from a Buy to a Hold...

The bullish case for Zoetis Inc (NYSE: ZTS) has come to an end after the stock outperformed the S&P 500 index by 108 percent since spinning out from Pfizer Inc. (NYSE: PFE), according to Stifel. The Analyst Stifel's Jonathan Block downgraded Zoetis from Buy to Hold with a $95...

Not a month into Inspire Medical Systems Inc (NYSE: INSP)’s life as a publicly traded company, the Street is coming to consensus. Two bulls and a fence-sitter issued their opinions Tuesday. The Rating Stifel Nicolaus analyst Jonathan Block initiated coverage of Inspire with a Buy rating and...

IntriCon Corporation (NASDAQ: IIN), a medical technology company and major supplier to  Medtronic PLC (NYSE: MDT)'s diabetes division, is "one of the more interesting and undiscovered small-cap names" in its sector, according to Stifel.  The Analyst Analyst Jonathan...

The bullish case for Glaukos Corp (NYSE: GKOS), a company focusing on designing products and procedures for the treatment of glaucoma, is based on expectations the company will stabilize its micro-invasive glaucoma surgery concomitant market share in 2019. But after speaking with dozens of doctors...

Aratana Therapeutics Inc (NASDAQ: PETX), which has a portfolio treatments for pet diseases and disorders, is likely to ride high on product momentum, according to Stifel.  The Analyst Analyst Jonathan Block upgraded shares of Aratana from Hold to Buy and raised the price target from $6 to $...

Patterson Companies, Inc. (NASDAQ: PDCO), a distributor of consumable dental products and other services, is expected to see pressure in the coming years to its growth profile and market share take, according to analysts at Stifel. Stifel's Jonathan Block downgrades Patterson's stock rating from...

Earlier this month, Invisalign maker Align Technology, Inc. (NASDAQ: ALGN) beat on both top- and bottom-line Q3 estimates, and shares have been up around 10 percent since. Stifel analyst Jonathan Block increased his price target for the stock from $95 to $110, representing a 15 percent upside from...

Stifel's Jonathan Block initiated coverage on Zoetis Inc (Nyse: ZTS) with a Buy rating and a price target of $58.00. Block estimated that "worldwide peak sales could reach $400 to $500 million versus management's estimate of > $300 million." He envisions the company will...